The Federal Circuit limits the reach of the on sale bar and provides guidance to pharmaceutical companies that rely on the use of contract manufacturers. Bruce Haas and Lauren Zuffante discuss.
08/11/2016 | Managing Intellectual Property Blog
1 min
March 11, 2026
February 23, 2026
February 09, 2026
March 04, 2026
March 04, 2026
February 27, 2026